Valentina Belli
Valentina Belli
UniversitÓ degli Studi della Campania "Luigi Vanvitelli"
Verified email at
Cited by
Cited by
Transport across the cell-membrane dictates nanoparticle fate and toxicity: a new paradigm in nanotoxicology
D Guarnieri, S Sabella, O Muscetti, V Belli, MA Malvindi, S Fusco, ...
Nanoscale 6 (17), 10264-10273, 2014
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
PP Vitiello, C Cardone, G Martini, D Ciardiello, V Belli, N Matrone, G Barra, ...
Journal of Experimental & Clinical Cancer Research 38, 1-12, 2019
EPHA2 is a predictive biomarker of resistance and a potential therapeutic target for improving antiepidermal growth factor receptor therapy in colorectal cancer
G Martini, C Cardone, PP Vitiello, V Belli, S Napolitano, T Troiani, ...
Molecular Cancer Therapeutics 18 (4), 845-855, 2019
Personality disorders in addiction outpatients: prevalence and effects on psychosocial functioning
P Casadio, D Olivoni, B Ferrari, C Pintori, E Speranza, M Bosi, V Belli, ...
Substance Abuse: Research and Treatment 8, SART. S13764, 2014
Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity
D Guarnieri, MA Malvindi, V Belli, PP Pompa, P Netti
Journal of nanoparticle research 16 (2), 2229, 2014
Dynamics of nanoparticle diffusion and uptake in three-dimensional cell cultures
V Belli, D Guarnieri, M Biondi, F Della Sala, PA Netti
Colloids and Surfaces B: Biointerfaces 149, 7-15, 2017
Metabolomic approach for a rapid identification of natural products with cytotoxic activity against human colorectal cancer cells
V Graziani, M Scognamiglio, V Belli, A Esposito, B D’Abrosca, ...
Scientific Reports 8 (1), 5309, 2018
Sub-100 nm biodegradable nanoparticles: in vitro release features and toxicity testing in 2D and 3D cell cultures
M Biondi, D Guarnieri, H Yu, V Belli, PA Netti
Nanotechnology 24 (4), 045101, 2013
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
DOI: 10.18632/oncotarget.20054, 2017
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
MF Della Corte CM, Malapelle U, Vigliar E, Pepe F, Troncone G, Ciaramella V ...
Oncotarget. 2017 Apr 4;8(14):23020-23032. doi: 10.18632/oncotarget.15479., 2017
Tumor‐activated prodrug (TAP)‐conjugated nanoparticles with cleavable domains for safe doxorubicin delivery
D Guarnieri, M Biondi, H Yu, V Belli, AP Falanga, M Cantisani, S Galdiero, ...
Biotechnology and bioengineering 112 (3), 601-611, 2015
Multilayered silica-biopolymer nanocapsules with a hydrophobic core and a hydrophilic tunable shell thickness
R Vecchione, G Luciani, V Calcagno, A Jakhmola, B Silvestri, D Guarnieri, ...
Nanoscale 8 (16), 8798-8809, 2016
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer
C Cardone, B Blauensteiner, V Moreno-Viedma, G Martini, V Simeon, ...
European Journal of Cancer 138, 1-10, 2020
Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells
F Morgillo, CM Della Corte, A Diana, C di Mauro, V Ciaramella, G Barra, ...
Oncotarget 8 (44), 76479, 2017
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression
S Napolitano, N Matrone, AL Muddassir, G Martini, A Sorokin, V De Falco, ...
Journal of Experimental & Clinical Cancer Research 38, 1-18, 2019
Biocompatible nanoparticles sensing the matrix metallo-proteinase 2 for the on-demand release of anticancer drugs in 3D tumor spheroids
M Cantisani, D Guarnieri, M Biondi, V Belli, M Profeta, L Raiola, PA Netti
Colloids and Surfaces B: Biointerfaces 135, 707-716, 2015
Biostability enhancement of oil core—polysaccharide multilayer shell via photoinitiator free thiol-ene ‘click’reaction
V Calcagno, R Vecchione, A Sagliano, A Carella, D Guarnieri, V Belli, ...
Colloids and Surfaces B: Biointerfaces 142, 281-289, 2016
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer
PP Vitiello, G Martini, L Mele, EF Giunta, V De Falco, D Ciardiello, V Belli, ...
Journal of Experimental & Clinical Cancer Research 40, 1-15, 2021
Bioinspired oil core/silica shell nanocarriers with tunable and multimodal functionalities
A Jakhmola, R Vecchione, D Guarnieri, V Belli, D Calabria, PA Netti
Advanced Healthcare Materials 4 (17), 2688-2698, 2015
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models
V Belli, N Matrone, S Napolitano, G Migliardi, F Cottino, A Bertotti, ...
Journal of Experimental & Clinical Cancer Research 38, 1-14, 2019
The system can't perform the operation now. Try again later.
Articles 1–20